Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756335 · ClinicalTrials.gov registry record · NA
The Brain Metabolism of Unpredictable Signals
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05756335: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05756335 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05756335, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The investigators will be studying brain glucose and oxygen metabolism using hybrid PET/fMRI imaging to better understand how decoupling between brain glucose and oxygen metabolism relates to the processing of unpredictable sensory signals.
Interventions
- BEHAVIORAL (Un)predictable and (un)attended stimuli
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2026-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05756335
The ClinicalTrials.gov registry entry for NCT05756335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which (Un)predictable and (un)attended stimuli is the first listed.
NCT05756335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05756335 about?
NCT05756335 is a clinical study titled "The Brain Metabolism of Unpredictable Signals". The investigators will be studying brain glucose and oxygen metabolism using hybrid PET/fMRI imaging to better understand how decoupling between brain glucose and oxygen metabolism relates to the processing of unpredictable sensory signals.
What is the current status of trial NCT05756335?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2024-04-05. Estimated completion is 2026-02-12.
What interventions are being tested in trial NCT05756335?
The interventions under investigation include: (Un)predictable and (un)attended stimuli (BEHAVIORAL).
Who is sponsoring clinical trial NCT05756335?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.